Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(15):1116; doi:10.1093/jnci/dji263
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hayasaka, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hayasaka, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

In Brief

Elana Hayasaka

The first 10% of the full text of this article appears below.

Study Finds No Best PSA Value for Decision to Biopsy

For the popular prostate cancer screening test that measures prostate-specific antigen (PSA), no specific value exists that is sensitive enough to detect cancer cases but not yield a high rate of false positives, according to a new study published in . . . [Full Text of this Article]

Fear of Lawsuits May Affect Radiology Practices


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?